Literature DB >> 36267934

Role of Procalcitonin in the Prognosis of Mortality in Patients Admitted to the Intensive Care Unit: A Review Study.

Mahdiye Jafari1, Farzaneh Fazeli1, Majid Sezavar2, Sara Khashkhashi1, Benyamin Fazli1, Nooshin Abdollahpour3, Alireza Sedaghat4.   

Abstract

Background: This review study aimed to investigate the role of PCT in the prognosis of mortality among patients admitted to the intensive care units (ICU). Procalcitonin (PCT) is a polypeptide and prohormone of calcitonin. This prohormone is secreted by thyroid gland C cells in response to hypercalcemia, and Its elevated level indicates infection, especially bacterial infections, in which there is a systematic response to infection. Materials and
Methods: This narrative review study was performed based on Cochrane collaboration recommendations for reviews. We reviewed all the titles and abstracts of published research articles with the following inclusion criteria studies aimed to confirm the function of a prognostic model in predicting mortality or survival, (b) mortality or survival of a specific endpoint (for example, 30 days), (c) patients admitted to intensive care units, and d) the articles written in English. The exclusion criteria of the current review included: (a) articles whose data were not specifically focused on prognosis of patients in ICU, (b) articles that did not provide sufficient information on the cause of death of patients in ICU, and (c) articles focusing on the treatment of comorbid patients with infections in ICU. The search was conducted on Google Scholar, PubMed, Magiran, ScienceDirect, and SID. Also, to search Iranian databases, including SID and Magiran, the same terms and expressions were searched.
Results: Based on the findings of this review, serum levels of PCT were reported within the range of at least 5 to more than 16 ng/ml in patients admitted to ICU. The mortality rate was estimated at 5.7% to 79% in these patients. Moreover, the incidence of sepsis was reported from 13% to 77.6%.
Conclusion: Serum levels of PCT as a prognostic factor may help early detection, and better classification of the poor prognoses sepsis patients and more invasive treatment of patients admitted to ICU and are at risk for mortality. Copyright
© 2021 National Research Institute of Tuberculosis and Lung Disease.

Entities:  

Keywords:  Procalcitonin; Prognosis; Prophylaxis; Sepsis

Year:  2021        PMID: 36267934      PMCID: PMC9577211     

Source DB:  PubMed          Journal:  Tanaffos        ISSN: 1735-0344


  53 in total

Review 1.  Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis.

Authors:  Samantha Eschborn; Joern-Hendrik Weitkamp
Journal:  J Perinatol       Date:  2019-03-29       Impact factor: 2.521

2.  Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications.

Authors:  B Adamik; J Kübler-Kielb; B Golebiowska; A Gamian; A Kübler
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

Review 3.  Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis.

Authors:  Christina Wacker; Anna Prkno; Frank M Brunkhorst; Peter Schlattmann
Journal:  Lancet Infect Dis       Date:  2013-02-01       Impact factor: 25.071

Review 4.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis.

Authors:  Kuan-Ho Lin; Feng-Lin Wang; Meng-Shu Wu; Bing-Yan Jiang; Wei-Liang Kao; Hsiao-Yun Chao; Jiunn-Yih Wu; Chien-Chang Lee
Journal:  Diagn Microbiol Infect Dis       Date:  2014-05-21       Impact factor: 2.803

5.  Comparison of Ranson, Glasgow, MOSS, SIRS, BISAP, APACHE-II, CTSI Scores, IL-6, CRP, and Procalcitonin in Predicting Severity, Organ Failure, Pancreatic Necrosis, and Mortality in Acute Pancreatitis.

Authors:  Ajay K Khanna; Susanta Meher; Shashi Prakash; Satyendra Kumar Tiwary; Usha Singh; Arvind Srivastava; V K Dixit
Journal:  HPB Surg       Date:  2013-09-24

6.  Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study.

Authors:  Philipp Schuetz; Robert Birkhahn; Robert Sherwin; Alan E Jones; Adam Singer; Jeffrey A Kline; Michael S Runyon; Wesley H Self; D Mark Courtney; Richard M Nowak; David F Gaieski; Stefan Ebmeyer; Sascha Johannes; Jan C Wiemer; Andrej Schwabe; Nathan I Shapiro
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

7.  Prospective evaluation of serum procalcitonin in critically ill patients with suspected sepsis- experience from a tertiary care hospital in Pakistan.

Authors:  Sibtain Ahmed; Imran Siddiqui; Lena Jafri; Madiha Hashmi; Aysha Habib Khan; Farooq Ghani
Journal:  Ann Med Surg (Lond)       Date:  2018-10-05

8.  The usefulness of C-reactive protein and procalcitonin to predict prognosis in septic shock patients: A multicenter prospective registry-based observational study.

Authors:  Seung Mok Ryoo; Kap Su Han; Shin Ahn; Tae Gun Shin; Sung Yeon Hwang; Sung Phil Chung; Yoon Jung Hwang; Yoo Seok Park; You Hwan Jo; Hyung Lan Chang; Gil Joon Suh; Kyoung Min You; Gu Hyun Kang; Sung-Hyuk Choi; Tae Ho Lim; Won Young Kim
Journal:  Sci Rep       Date:  2019-04-29       Impact factor: 4.379

9.  Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery.

Authors:  Michail Yaroustovsky; Marina Plyushch; Dmitry Popov; Natalia Samsonova; Marina Abramyan; Zakhar Popok; Nickolay Krotenko
Journal:  J Inflamm (Lond)       Date:  2013-03-06       Impact factor: 4.981

10.  Procalcitonin Value Is an Early Prognostic Factor Related to Mortality in Admission to Pediatric Intensive Care Unit.

Authors:  Fatih Aygun
Journal:  Crit Care Res Pract       Date:  2018-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.